Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
Scientific Reports
|
November 15, 2019
Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia
Maria L Lozano, Maria E Mingot-Castellano, María M Perera, et al.
Journal of Thrombosis and Thrombolysis
|
March 11, 2025
Significant attenuation of fully automated thrombin generation in newly diagnosed multiple myeloma patients after induction therapy
Diego Velasco-Rodríguez, Inés Martínez-Alfonzo, Alberto Eterio Velasco-Valdazo, et al.
American Journal of Hematology
|
December 16, 2020
A novel genetic variant in PTGS1 affects N-glycosylation of cyclooxygenase-1 causing a dominant-negative effect on platelet function and bleeding diathesis
Verónica Palma-Barqueros, Marilena Crescente, María Eugenia de la Morena, et al.
The Lancet. Haematology
|
June 15, 2024
Thrombotic risk and features of patients with inferior vena cava agenesis: a multicentre, retrospective, observational study
Carlos Bravo-Pérez, Ana Blanco, Nuria Revilla, et al.
British Journal of Haematology
|
July 16, 2025
Insights into the clinical, platelet and genetic landscape of inherited thrombocytopenia with malignancy risk
Ana Marín-Quílez, Ana Sánchez-Fuentes, Ana Zamora-Cánovas, et al.
American Journal of Hematology
|
October 12, 2024
Avatrombopag in immune thrombocytopenia: A real-world study of the Spanish ITP Group (GEPTI)
Cristina Pascual-Izquierdo, Blanca Sánchez-González, Mariana-Isabel Canaro-Hirnyk, et al.
British Journal of Haematology
|
May 30, 2026
Switching patients with immune thrombocytopenia (ITP) to avatrombopag from other thrombopoietin receptor agonists: The real-world experience of the Spanish ITP Group (GEPTI)
Cristina Pascual-Izquierdo, José-María Bastida, David Valcárcel, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
Scientific Reports
|
November 15, 2019
Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia
Maria L Lozano, Maria E Mingot-Castellano, María M Perera, et al.
Journal of Thrombosis and Thrombolysis
|
March 11, 2025
Significant attenuation of fully automated thrombin generation in newly diagnosed multiple myeloma patients after induction therapy
Diego Velasco-Rodríguez, Inés Martínez-Alfonzo, Alberto Eterio Velasco-Valdazo, et al.
American Journal of Hematology
|
December 16, 2020
A novel genetic variant in PTGS1 affects N-glycosylation of cyclooxygenase-1 causing a dominant-negative effect on platelet function and bleeding diathesis
Verónica Palma-Barqueros, Marilena Crescente, María Eugenia de la Morena, et al.
The Lancet. Haematology
|
June 15, 2024
Thrombotic risk and features of patients with inferior vena cava agenesis: a multicentre, retrospective, observational study
Carlos Bravo-Pérez, Ana Blanco, Nuria Revilla, et al.
British Journal of Haematology
|
July 16, 2025
Insights into the clinical, platelet and genetic landscape of inherited thrombocytopenia with malignancy risk
Ana Marín-Quílez, Ana Sánchez-Fuentes, Ana Zamora-Cánovas, et al.
American Journal of Hematology
|
October 12, 2024
Avatrombopag in immune thrombocytopenia: A real-world study of the Spanish ITP Group (GEPTI)
Cristina Pascual-Izquierdo, Blanca Sánchez-González, Mariana-Isabel Canaro-Hirnyk, et al.
British Journal of Haematology
|
May 30, 2026
Switching patients with immune thrombocytopenia (ITP) to avatrombopag from other thrombopoietin receptor agonists: The real-world experience of the Spanish ITP Group (GEPTI)
Cristina Pascual-Izquierdo, José-María Bastida, David Valcárcel, et al.
Page
of 3